Sharing the News at Work

 
Sharing the news with co-workers that you have cancer is a deeply personal decision.  How open you are will depend on many factors, including the type of environment you work in, your relationships with your co-workers, and your personality. Truthfully, you don't have to tell anyone.

But if you do, you might be surprised by your colleagues' understanding and compassion.  It could also help clear the air and remove some of the awkwardness each of you may be feeling, especially if you've been absent from work for awhile or have suddenly started wearing a wig.

Some co-workers may approach you and want to talk about your illness; others may avoid you because they feel uncomfortable talking about your illness. Or, they may think that they are invading your privacy and don't want to intrude on something so personal.  Remember, everyone's reaction will be different.

Here are a few tips and suggestions for handling various situations:

  • If you want your co-workers to know about your cancer, but don't want to be in the position of having to talk about your illness on a regular basis, consider saying something like this once, "I wanted you to know that I am receiving treatment for cancer. But I'm really not comfortable talking about it; that's just the way I find I cope best.  I appreciate your support and your thinking about me."
  • If, on the other hand, you draw comfort and inspiration from talking with your co-workers about your condition, let them know.  Thank them for their words of encouragement and signal to them that you're OK with talking about your illness. Consider using a little humor to put them at ease. Remember, many people want to be supportive but find it difficult to often find the "right" words to say.
Latest Cancer News
ACOG Updates Cervical Cancer Screening Guidelines

November 20, 2009 — The American College of Obstetricians and Gynecologists (ACOG) has revised its cervical cancer screening recommendations: the organization now recommends that women begin screening at the age of 21 and receive screening at less frequent intervals. These recommendations will be published in the December 2009 issue of Obstetrics and Gynecology.

New Velcade®-melphalan Transplant Regimen for Multiple Myeloma

November 20, 2009 — Researchers from France have reported encouraging results with adding Velcade® (bortezomib) to high-dose melphalan followed by autologus stem cell infusion for initial treatment of patients with newly diagnosed multiple myeloma. The details of this Phase II study appeared in an early online publication in Blood on November 2, 2009.

Folic Acid May Be Beneficial in Patients with Recurrent Colorectal Adenoma Who Are Folate Deficient

November 20, 2009 — Researchers affiliated with the Health Professional Follow-Up Study and the Nurses’ Health Study have reported that folic acid supplementation in patients with recurrent colorectal adenoma was not protective or harmful in most patients. However, patients who were folate deficient had a significant 39% decrease in adenoma recurrence. The details of this study appeared in an early online publication on October 28, 2009 in the American Journal of Clinical Nutrition.

Select news items provided by Reuters Health